PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼

Showing posts with label Diabetes. Show all posts

Showing posts with label Diabetes. Show all posts

Novo Nordisk completes fourth phase 3a trial with semaglutide

Novo Nordisk announced the headline results from the fourth phase 3a trial for semaglutide, SUSTAIN2. Semaglutide is a new GLP-1 analogue a...

Novo Nordisk files for regulatory approval of faster-acting insulin

Novo Nordisk announced the submission to the European Medicines Agency of the Marketing Authorisation Application (MAA) for the approval ...

Victoza provides greater glycaemic control

New findings from a network meta-analysis show that treatment with Victoza ® (liraglutide) provides a greater HbA 1c reduction and an imp...

US FDA approves Tresiba and Ryzodeg

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Tresiba ® and Ryzodeg ® 70/30 for the treatment...

Lilly and Sanofi Reach Settlement Agreement

Eli Lilly and Company has entered into a settlement agreement to resolve patent litigation with Sanofi regarding its insulin glargine produ...

View web version

Powered by Blogger.